Daclatasvir is a direct-acting antiviral tablet used, usually with sofosbuvir, to treat chronic hepatitis C.
Reference information, not medical advice — always follow your doctor or pharmacist. Source: WHO Model List of Essential Medicines (eMLW), list.essentialmeds.org, daclatasvir entry; WHO hepatitis C fact sheet, who.int (accessed 2026-08-16)
| Brand name | Dosage form | Strength | Importer | Category |
|---|---|---|---|---|
| Daclatasvir | Tablet | — | POM | |
| Daclatasvir | Tablet | — | POM | |
| Daclatasvir | Tablet | — | POM |